Xavier   Llor, MD, PhD

Xavier Llor, MD, PhD

Yale Cancer Center/Smilow Cancer Hospital

Professor of Medicine; Associate CEHE Director for Cancer Screening, Smilow Cancer Hospital; Medical Director, Cancer Screening and Prevention Program, and Colorectal Cancer Prevention Program, Yale Cancer Center

Expertise: Cancer GeneticsCancer GeneticsCancer ScreeningCancer ScreeningColorectal CancerColorectal Cancer

After obtaining his MD degree from the Autonomous University Barcelona, Dr. Llor trained in basic research and Internal Medicine at the University of Chicago and completed his GI fellowship at the University of Illinois at Chicago. He complemented his training with a PhD degree in molecular biology from the University of Barcelona. A clinically active gastroenterologist, Dr. Llor’s research and clinical interests relate to colorectal cancer. He has a very active basic and translational research program mainly focusing on two different aspects of colorectal cancer: hereditary and familial forms, and disparities in colorectal cancer. This work has resulted in almost 100 scientific publications in this field. He has made seminal contributions to the field of Lynch syndrome diagnosis as well as in the definition of other non-polyposis syndromic colorectal cancer cases. Some of his most recent work is providing important clues to the understanding of the biological differences that contribute to disparities in colorectal cancer. Watch a video with Dr. Xavier Llor >>

Dr. Llor is the Co-Director of the Smilow Cancer Genetics and Prevention Program; Director for Cancer Screening; and Medical Director of the Colorectal Cancer Prevention Program at Yale University and Smilow Cancer Hospital and he sees patients at Yale. He is a member of the steering committee of the National Colorectal Cancer Round Table (NCCRT) and member of the National Comprehensive Cancer Network (NCCN) guidelines panels for colorectal cancer screening and colorectal cancer genetics. He is commonly invited to lecture in colorectal cancer genetics in the US and abroad.

No Clipping

No Research/Citations

Why Are Colorectal Cancer Rates Rising Among Younger Adults?

Nearly double the number of young adults under 55 are being diagnosed with colorectal cancer than a decade ago. This most recent significant increase in CRC among the younger population, Dr. Xavier Llor says, is more associated with a patient’s environment, including all sorts of exposures, and diet.
27-Mar-2023 05:35:20 PM EDT

Raising Awareness About Colorectal Cancer

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine’s Section of Digestive Diseases are redoubling their efforts to spread the word about the importance of screening, especially in younger individuals and those with a family history of the disease. Colorectal cancer is the second most common cause of cancer death in the United States.
10-Mar-2023 06:25:36 PM EST

Yale Cancer Center launches Center for Community Engagement and Health Equity

Yale Cancer Center (YCC) announces the launch of the Center for Community Engagement and Health Equity (CEHE). Building on YCC’s longstanding commitment to high-quality, expert, and patient-centered cancer care, screening, and prevention across the state of Connecticut, the new Center is dedicated to ensuring cancer health equity and improving outcomes with an emphasis on traditionally underserved neighborhoods.
26-Dec-2019 11:50:38 AM EST

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

close
0.09784